Brian G. Drazba - 05 Jul 2022 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Reporting relationship
Chief Financial Officer
Issuer ticker
MEIP
Reported as of
05 Jul 2022
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
07 Jul 2022, 16:23:59 UTC
Prior SEC filing
06 Jul 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brian G. Drazba

Key filing fact

Brian G. Drazba filed Form 4 for MEI Pharma, Inc. (MEIP) on 07 Jul 2022.

Key facts

  • This page summarizes Brian G. Drazba's Form 4 filing for MEI Pharma, Inc. (MEIP).
  • 1 reported transaction and 8 derivative rows are listed below.
  • Accepted by SEC: 07 Jul 2022, 16:23.

Change

  • Previous filing in this sequence was filed on 06 Jul 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MEIP transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+350,000
Change %
Price
$0.000000
Shares after
350,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
350,000
Exercise price
$0.5400
Footnotes
F1
MEIP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
200,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200,000
Exercise price
$2.95
Footnotes
F2
MEIP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
150,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
150,000
Exercise price
$1.59
Footnotes
F3
MEIP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
50,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,000
Exercise price
$2.83
Footnotes
F3
MEIP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
130,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
130,000
Exercise price
$4.33
Footnotes
F3
MEIP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
100,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
100,000
Exercise price
$4.28
Footnotes
F4
MEIP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
230,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
230,000
Exercise price
$2.52
Footnotes
F5
MEIP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
230,000
Date
05 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
230,000
Exercise price
$3.49
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.

Footnote F2

One-quarter of such options vested on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.

Footnote F3

All of such options are presently exercisable.

Footnote F4

One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.

Footnote F5

One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.

Footnote F6

One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .